Department of Pediatric Neurology, Hospital Universitari Vall d'Hebron, Vall d´Hebron Institut de Recerca, Barcelona, Spain.
Universitat Autònoma de Barcelona, Barcelona, Spain.
Ann Clin Transl Neurol. 2020 Aug;7(8):1436-1442. doi: 10.1002/acn3.51095. Epub 2020 Aug 6.
FBXO7 is implicated in the ubiquitin-proteasome system and parkin-mediated mitophagy. FBXO7defects cause a levodopa-responsive parkinsonian-pyramidal syndrome(PPS).
We investigated the disease molecular bases in a child with PPS and brain iron accumulation.
A novel homozygous c.368C>G (p.S123*) FBXO7 mutation was identified in a child with spastic paraplegia, epilepsy, cerebellar degeneration, levodopa nonresponsive parkinsonism, and brain iron deposition. Patient's fibroblasts assays demonstrated an absence of FBXO7 RNA expression leading to impaired proteasome degradation and accumulation of poly-ubiquitinated proteins.
This novel FBXO7 phenotype associated with impaired proteasome activity overlaps with neurodegeneration with brain iron accumulation disorders.
FBXO7 参与泛素蛋白酶体系统和 parkin 介导的线粒体自噬。FBXO7 缺陷可导致左旋多巴反应性帕金森-锥体综合征(PPS)。
我们研究了一名具有 PPS 和脑铁积累的患儿的疾病分子基础。
在一名痉挛性截瘫、癫痫、小脑变性、左旋多巴无反应性帕金森病和脑铁沉积的患儿中发现了一种新的纯合 c.368C>G(p.S123*)FBXO7 突变。患者的成纤维细胞检测表明 FBXO7 RNA 表达缺失,导致蛋白酶体降解受损和多聚泛素化蛋白堆积。
这种新的与蛋白酶体活性受损相关的 FBXO7 表型与伴有脑铁蓄积的神经退行性疾病重叠。